In our integrated genomic and clinical analysis of TCGA, CDKN2A copy number loss was associated with poor prognosis in HPV-negative head and neck cancer independently of other known prognostic factors including age, advanced tumor stage, and African American race (13, 14, 27). The gene discussed is CDKN2A; the disease is neoplasm.